BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1530293)

  • 1. [Effect of intratumoral injection of the mixture of OK-432 and fibrinogen (OK/fbg) on gastric cancer].
    Takeda T; Wakasugi T; Katsumoto Y; Sakita I; Nagaoka H; Morimoto H; Tsujinaka T; Monden T; Shiozaki H; Shimano T
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1458-60. PubMed ID: 1530293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of urokinase-type plasminogen activator in local immunotherapy.
    Takeda T; Ito Y; Wakasugi E; Kobayashi T; Monden M
    Oncol Rep; 1998; 5(2):329-33. PubMed ID: 9468551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intratumoral injection of OK-432 in conjunction with fibrinogen greatly enhances antitumor effect on colorectal carcinomas].
    Monden T; Morimoto H; Murotani M; Yagyu T; Nagaoka H; Shimano T; Mori T
    Nihon Geka Gakkai Zasshi; 1991 Jan; 92(1):31-6. PubMed ID: 1707498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of endoscopic local injection of OK-432 on regional lymph nodes in gastric cancer patients].
    Ogawara T; Sakai K; Sekikawa T; Kouno K; Matsumoto Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1601-4. PubMed ID: 1530316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endoscopic preoperative intralesional injection of OK-432 in early gastric cancer].
    Yamane T; Sagara Y; Suzuki G; Kasuga M; Sakita M; Fujita Y; Majima S
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):930-4. PubMed ID: 6721507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].
    Kobayashi G
    Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):68-76. PubMed ID: 2314383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augumentation of splenic antitumor immunity by local immunotherapy in gastric cancer patients.
    Wakasugi T; Takeda T; Monden T; Katsumoto Y; Sakita I; Nagaoka H; Fukunaga M; Tomita N; Kobayashi T; Shiozaki H; Shimano T; Monden M
    Biotherapy; 1997; 10(2):99-106. PubMed ID: 9373731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preoperative immunotherapy in patients with gastric cancer--with special reference to analysis with monoclonal antibodies of T-lymphocyte subsets and interleukin-2 oral administration of OK-432 (Picibanil)].
    Izumi M
    Nihon Geka Gakkai Zasshi; 1993 Jan; 94(1):27-32. PubMed ID: 8437550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of immunological response of regional lymph node lymphocytes from patients with gastric cancer after endoscopic local injection of biological response modifier (BRM)].
    Obi Y
    Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):293-302. PubMed ID: 2051981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adoptive immunotherapy against peritoneal metastases from stomach cancer--application of regional lymph node lymphocytes].
    Okino T; Kan N; Mise K; Nakanishi M; Satoh K; Yamasaki S; Teramura Y; Inoue K; Ohgaki K; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):613-20. PubMed ID: 2351854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of local immunotherapy for breast cancer using a mixture of OK-432 and fibrinogen supplemented with activated macrophages.
    Takeda T; Kobayashi T; Monden T; Katsumoto Y; Ito Y; Wakasugi E; Wakasugi T; Tomita N; Shimano T; Mori T
    Biotherapy; 1993; 7(1):47-54. PubMed ID: 8068483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A patient with unresectable cancer of pancreas head, effectively treated by a local injection of the mixture of OK-432, fibrinogen and thrombin].
    Takekuni K; Sakon M; Kishimoto S; Amano M; Sekimoto M; Aoki T; Oosato H; Dohno K; Umeshita K; Gotoh M; Monden T; Monden M
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1621-3. PubMed ID: 8854822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
    Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
    Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endoscopic administration of OK-432 in gastric cancer].
    Inbe A; Sumii K; Haruma K; Uemura N; Tari A; Yoshihara M; Tokutomi T; Inaba Y; Sekito M; Ogoshi H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):514-9. PubMed ID: 3954375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The immune defense system in gastric cancer tissue, regional lymph node and spleen--aspects from subsets and functions of lymphocytes].
    Tanaka N; Gohchi A; Akura Y; Gotoh K; Okabayashi T; Horimi T; Orita K
    Nihon Geka Gakkai Zasshi; 1985 Sep; 86(9):1112-5. PubMed ID: 4088222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subsets of peripheral blood lymphocytes and tumor infiltrating lymphocytes in cancer patients received chemotherapy].
    Mitachi Y; Murakawa Y; Okuno M; Kambe M; Kanamaru R; Takahasi H; Wakui A
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):482-8. PubMed ID: 2138871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
    Sakai Y; Maeda M; Koyama W; Totsuka S; Sakamoto S; Kanayama M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1978-80. PubMed ID: 3382244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of immunotherapy and spleen preservation on immunological function in patients with gastric cancer.
    Okinaga K; Iinuma H; Kitamura Y; Yokohata T; Inaba T; Fukushima R
    J Exp Clin Cancer Res; 2006 Sep; 25(3):339-49. PubMed ID: 17167974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients.
    Gochi A; Orita K; Fuchimoto S; Tanaka N; Ogawa N
    Br J Cancer; 2001 Feb; 84(4):443-51. PubMed ID: 11207036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective augmentations of intratumoral 5-fluorouracil concentration by local immunotherapy with OK-432 and fibrinogen.
    Amano M; Sekimoto M; Monden T; Tomita N; Ohue M; Haba A; Sakita I; Tamaki Y; Monden M
    Dis Colon Rectum; 2000 Mar; 43(3):402-7. PubMed ID: 10733124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.